These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 26021827)
41. Small heat shock protein 27: An effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity. Milani A; Bolhassani A; Shahbazi S; Motevalli F; Sadat SM; Soleymani S Immunol Lett; 2017 Nov; 191():16-22. PubMed ID: 28917624 [TBL] [Abstract][Full Text] [Related]
42. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Ge FF; Qiu YF; Yang YW; Chen PY Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385 [TBL] [Abstract][Full Text] [Related]
43. Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection. Kran AM; Sommerfelt MA; Baksaas I; Sørensen B; Kvale D APMIS; 2012 Mar; 120(3):204-9. PubMed ID: 22339677 [TBL] [Abstract][Full Text] [Related]
44. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Wille-Reece U; Flynn BJ; Loré K; Koup RA; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15190-4. PubMed ID: 16219698 [TBL] [Abstract][Full Text] [Related]
45. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice. Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951 [TBL] [Abstract][Full Text] [Related]
46. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years. Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485 [TBL] [Abstract][Full Text] [Related]
47. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice. Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310 [TBL] [Abstract][Full Text] [Related]
48. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses. Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074 [TBL] [Abstract][Full Text] [Related]
49. Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection. Ayash-Rashkovsky M; Borkow G; Davis HL; Moss RB; Bartholomew R; Bentwich Z FASEB J; 2005 Jul; 19(9):1152-4. PubMed ID: 15833766 [TBL] [Abstract][Full Text] [Related]
50. Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. Bozzacco L; Yu H; Dengjel J; Trumpfheller C; Zebroski HA; Zhang N; Küttner V; Ueberheide BM; Deng H; Chait BT; Steinman RM; Mojsov S; Fenyö D PLoS One; 2012; 7(7):e41897. PubMed ID: 22860026 [TBL] [Abstract][Full Text] [Related]
51. Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production. Chung EJ; Jeong YI; Lee MR; Kim YJ; Lee SE; Cho SH; Lee WJ; Park MY; Ju JW Parasit Vectors; 2017 Mar; 10(1):118. PubMed ID: 28249599 [TBL] [Abstract][Full Text] [Related]
52. Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses. Lindh I; Bråve A; Hallengärd D; Hadad R; Kalbina I; Strid Å; Andersson S Vaccine; 2014 Apr; 32(20):2288-93. PubMed ID: 24631072 [TBL] [Abstract][Full Text] [Related]
53. Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation. Iglesias E; García D; Carrazana Y; Aguilar JC; Sánchez A; Gorobaya L; Blanco A Curr HIV Res; 2008 Sep; 6(5):452-60. PubMed ID: 18855656 [TBL] [Abstract][Full Text] [Related]
54. Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants. Jiang Y; Li M; Zhang Z; Gong T; Sun X Pharm Res; 2014 Oct; 31(10):2748-61. PubMed ID: 24792827 [TBL] [Abstract][Full Text] [Related]
55. Targeting dendritic cells to enhance DNA vaccine potency. You Z; Huang X; Hester J; Toh HC; Chen SY Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Franco D; Li W; Qing F; Stoyanov CT; Moran T; Rice CM; Ho DD Vaccine; 2010 Aug; 28(35):5676-85. PubMed ID: 20600494 [TBL] [Abstract][Full Text] [Related]
57. Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag. Kanekiyo M; Matsuo K; Hamatake M; Hamano T; Ohsu T; Matsumoto S; Yamada T; Yamazaki S; Hasegawa A; Yamamoto N; Honda M J Virol; 2005 Jul; 79(14):8716-23. PubMed ID: 15994765 [TBL] [Abstract][Full Text] [Related]
58. [Influence of JEV E-HSP70 (Mycobacterium tuberculosis) fusion protein on immune response in BALB/c mice]. Ge FF; Qiu YF; Yang YW; Chen PY Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):441-5. PubMed ID: 15989243 [TBL] [Abstract][Full Text] [Related]
59. Enhanced activation of T lymphocytes by urease-deficient recombinant bacillus Calmette-Guérin producing heat shock protein 70-major membrane protein-II fusion protein. Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M J Immunol; 2010 Nov; 185(10):6234-43. PubMed ID: 20935209 [TBL] [Abstract][Full Text] [Related]